genOway Société anonyme (EPA:ALGEN)

genOway Société anonyme Statistics

Total Valuation

EPA:ALGEN has a market cap or net worth of EUR 25.17 million. The enterprise value is 25.79 million.

Market Cap	25.17M
Enterprise Value	25.79M

Important Dates

The next estimated earnings date is Friday, September 19, 2025.

Earnings Date	Sep 19, 2025
Ex-Dividend Date	n/a

Share Statistics

EPA:ALGEN has 9.22 million shares outstanding.

Current Share Class	9.22M
Shares Outstanding	9.22M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.15%
Owned by Institutions (%)	n/a
Float	6.28M

Valuation Ratios

The trailing PE ratio is 13.75.

PE Ratio	13.75
Forward PE	n/a
PS Ratio	0.91
PB Ratio	1.36
P/TBV Ratio	1.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	14.09
EV / Sales	0.94
EV / EBITDA	6.62
EV / EBIT	19.77
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.30.

Current Ratio	2.03
Quick Ratio	1.87
Debt / Equity	0.30
Debt / EBITDA	1.43
Debt / FCF	n/a
Interest Coverage	8.90

Financial Efficiency

Return on equity (ROE) is 10.18% and return on invested capital (ROIC) is 3.34%.

Return on Equity (ROE)	10.18%
Return on Assets (ROA)	2.56%
Return on Invested Capital (ROIC)	3.34%
Return on Capital Employed (ROCE)	5.62%
Revenue Per Employee	195,258
Profits Per Employee	12,984
Employee Count	141
Asset Turnover	0.87
Inventory Turnover	12.35

Taxes

Income Tax	-23,135
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.72% in the last 52 weeks. The beta is 0.45, so EPA:ALGEN's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-28.72%
50-Day Moving Average	3.09
200-Day Moving Average	3.32
Relative Strength Index (RSI)	25.20
Average Volume (20 Days)	2,002

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EPA:ALGEN had revenue of EUR 27.53 million and earned 1.83 million in profits.

Revenue	27.53M
Gross Profit	14.73M
Operating Income	1.30M
Pretax Income	1.81M
Net Income	1.83M
EBITDA	3.89M
EBIT	1.30M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 4.95 million in cash and 5.58 million in debt, giving a net cash position of -622,976 or -0.07 per share.

Cash & Cash Equivalents	4.95M
Total Debt	5.58M
Net Cash	-622,976
Net Cash Per Share	-0.07
Equity (Book Value)	18.57M
Book Value Per Share	n/a
Working Capital	8.86M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 53.49%, with operating and profit margins of 4.74% and 6.65%.

Gross Margin	53.49%
Operating Margin	4.74%
Pretax Margin	6.57%
Profit Margin	6.65%
EBITDA Margin	14.14%
EBIT Margin	4.74%
FCF Margin	n/a

Dividends & Yields

EPA:ALGEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7.27%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EPA:ALGEN has an Altman Z-Score of 3.09 and a Piotroski F-Score of 4.

Altman Z-Score	3.09
Piotroski F-Score	4